Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY-NCJournal for immunotherapy of cancer

Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.

  • Yunbo Yu1,2
  • Yuheng Liu1,2
  • Xin Zhang1,2
  • Wenyue Yang1,2
  • Sencong Hou1,2
  • Wenqian Yu3
  • Feifei Zhang3
  • Bo Yu1
  • Zhihuang Hu1
  • Zhenhua Wu1
  • Shenglin Huang2,4
  • Jialei Wang5
5 affiliations
  1. 1Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  2. 2Department of Oncology, Fudan University, Shanghai, China.
  3. 3Fudan University Shanghai Cancer Center, Shanghai, China.
  4. 4Shanghai Key Laboratory of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  5. 5Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China [email protected].
Read full textPDFDOICite

Related

  1. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
    J.M. Molina, Constance Delaugerre, J. Le Goff +4
    Médecine et Maladies Infectieuses FormationPeer-reviewedLicence not statedFull text747 citedInfectious diseaseHAL
  2. Conditional willingness to care for patients with Ebola virus disease: a qualitative study of risk-benefit perceptions and support needs of clinical students at a Ugandan medical school
    B. C. Nakabuubi, R. Nabunya, T. D. Ngabirano +8
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  3. Adjunctive pirenoxine is associated with transient tear biomarker changes without sustained ocular surface benefit after refractive surgery: a randomized clinical trial
    Phit Upaphong, Nattayaporn Apaijai, Napaporn Tananuvat +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  4. Association of pre-existing cardiovascular disease with cardiovascular and clinical outcomes in patients receiving immune checkpoint inhibitors
    Lama Alfehaid, Ahmed S. Alanazi, Mansour Alomran +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  5. Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
    Sungho Bea, Elisabetta Patorno, Sushama Kattinakere Sreedhara +5
    Diabetes carePeer-reviewedLicence not statedFull textEpidemiology & public healthPMC

Cite

BibTeXRIS
BibTeX
@article{yu2026plasma,
  title = {{Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.}},
  author = {Yunbo Yu and Yuheng Liu and Xin Zhang and Wenyue Yang and Sencong Hou and Wenqian Yu and Feifei Zhang and Bo Yu and Zhihuang Hu and Zhenhua Wu and Shenglin Huang and Jialei Wang},
  journal = {Journal for immunotherapy of cancer},
  year = {2026},
  month = oct,
  doi = {10.1136/jitc-2026-015873},
  url = {https://europepmc.org/article/MED/42875050},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.
AU  - Yunbo Yu
AU  - Yuheng Liu
AU  - Xin Zhang
AU  - Wenyue Yang
AU  - Sencong Hou
AU  - Wenqian Yu
AU  - Feifei Zhang
AU  - Bo Yu
AU  - Zhihuang Hu
AU  - Zhenhua Wu
AU  - Shenglin Huang
AU  - Jialei Wang
PY  - 2026
DA  - 2026/10/14
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-015873
UR  - https://europepmc.org/article/MED/42875050
SN  - 2051-1426
ER  -